Skip to main content
. 2009 Jul 7;157(8):1523–1530. doi: 10.1111/j.1476-5381.2009.00340.x

Table 1.

Concentrations and actions of pharmacological tools used

Agent Action Final concentration
ODQ Soluble guanylate cyclase inhibitor 10 µM
Indomethacin Cyclooxygenase inhibitor 5 µM
CPTIO Nitric oxide scavenger 1 mM
U-51605 Prostacyclin synthase inhibitor (PGISi) 10 µM
Raloxifene Aldehyde oxidase inhibitor 50 nM
Oxypurinol Xanthine oxidase inhibitor 100 µM
l-NMMA eNOS inhibitor 300 µM

These represent final bath concentrations required or established for maximum effect on nitrite-induced vasodilatation.

ODQ, 1H [1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; CPTIO, carboxy-2-phenyl-4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide; l-NMMA, l-NG-monomethyl arginine.